Pantoprazol Teva-Ratio (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Teva‑Ratio, is a proton pump inhibitor presented as an oral dosage form for oral use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive oesophagitis, peptic ulcer disease and as part of Helicobacter pylori eradication therapy. GNH USA supplies Pantoprazol Teva‑Ratio as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that reduces gastric acid production in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): alleviates heartburn and reflux symptoms by lowering stomach acidity. - Erosive oesophagitis: promotes healing of inflamed esophageal tissue caused by acid exposure. - Peptic ulcer disease: supports ulcer healing and prevents recurrence by maintaining a less acidic gastric environment. - Helicobacter pylori eradication therapy: enhances the effectiveness of antibiotic regimens by reducing gastric acidity.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate pain often resolving without intervention. - Diarrhea: loose stools that may be self‑limiting. - Nausea: sensation of unease or urge to vomit. - Abdominal pain: discomfort or cramping in the stomach area.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): swelling, difficulty breathing, or rash requiring immediate medical attention. - Clostridioides difficile infection: severe colitis presenting with watery diarrhea. - Low magnesium levels (hypomagnesemia): muscle cramps, irregular heartbeat, or seizures. - Liver enzyme elevation: signs of hepatic dysfunction detected via laboratory tests. - Stevens‑Johnson syndrome: rare skin blistering and mucosal involvement. - Interstitial nephritis: kidney inflammation presenting with reduced urine output or swelling.

Before initiating therapy, consider the following safety measures. - Renal function assessment: adjust use in patients with severe kidney impairment. - Magnesium monitoring: check serum levels during prolonged treatment. - Liver disease evaluation: use cautiously in hepatic impairment. - Elderly patients: start at the lowest effective dose and monitor for adverse effects. - Concomitant drug review: avoid or adjust use with medications that require gastric acidity for absorption. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several medicines.

Major Interactions (Avoid): - Clarithromycin: increased risk of elevated pantoprazole levels. - Ketoconazole: reduced absorption due to decreased gastric acidity. - Atazanavir: markedly decreased antiviral efficacy.

Moderate Interactions (Monitor Closely): - Digoxin: potential increase in serum concentration. - Methotrexate: reduced clearance leading to toxicity. - Rifampin: may lower pantoprazole effectiveness. - Phenytoin: possible alteration of plasma levels.